Where do Praxis Precision Medicines, Inc.'s ratios come from?

Every ratio is computed from Praxis Precision Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-35.3%+28.2pp	-45.8%+25.2pp	-75.2%-10.9pp	-61%-13.8pp	-63.6%+21.7pp
Return on assets	-33.7%+24.6pp	-42.7%+21.3pp	-67.2%-9.4pp	-56.2%-13.1pp	-58.3%+13.6pp
Return on invested capital	-62.2%+69.5pp	-86.8%—	-143.2%—	-103.9%—	-131.7%—
Liquidity
Current ratio	15.9×+7.4×	10.2×-0.5×	5.2×-5.8×	6.3×-11.0×	8.4×-2.8×
Quick ratio	15.9×+7.4×	10.2×-0.5×	5.2×-5.8×	6.3×-11.0×	8.4×-2.8×
Cash ratio	10.7×+6.5×	6×+0.2×	2.8×-2.3×	3.2×-3.8×	4.2×-3.9×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$48.82+134%	$39.02+56.9%	$15.63-22.9%	$18.82-15.5%	$20.86+26.3%
Valuation
Market capitalization	$8.97B+1,075%	$7.37B+414%	$1.12B+9.2%	$895.42M+26.5%	$763.58M-5.5%
Enterprise value	$8.44B+1,309%	$7.01B+475%	$966.12M+13.1%	$738.34M+30.9%	$598.67M-9.0%
Price / book	6.4×+4.6×	8.4×+5.2×	3.2×+0.6×	2.2×+0.5×	1.7×-1.8×
Free cash flow yield	-3.1%+18.3pp	-3.4%+5.8pp	-20.5%-10.8pp	-21.4%-7.9pp	-21.5%-9.2pp
Earnings yield	-3.6%+24.2pp	-4.1%+8.6pp	-24.5%-9.7pp	-28%-10.5pp	-27.8%-12.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Praxis Precision Medicines, Inc.'s ratios come from?: Every ratio is computed from Praxis Precision Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.